Mark Lawler, Associate Director of Postgraduate Studies, Chair in Translational Cancer Genomics, and Professor of Digital Health at Queen’s University Belfast, shared a post by The Cancer Drug Development Forum (CDDF) on LinkedIn, adding:
“Delighted to kick off our annual The Cancer Drug Development Forum (CDDF) here in Ghent – brilliant opening session. Highlight for me was doing a fire-side chat with Emer Cooke Executive Director of European Medicines Agency – what a leader… and she was appointed just as COVID hit but guided EMA through the pandemic. Great audience participation”
Quoting CDDF‘s post:
“We are thrilled to kick off the CDDF Annual Conference on “Cancer Clinical Research in a Changing Global Environment” in Ghent today.
We warmly welcome all participants to this unique, multi-stakeholder meeting, where open and constructive discussions will take place over the next three days.
Watch the welcome message from our Program Co-Chairs, Ruth Plummer and Mark Lawler. Check out today’s program and the speakers/panelists joining us:
“Session 1: What’s New in Global Clinical Development ?” followed by “CDDF Fireside Chat With Emer Cooke”
Speakers: Mark Lawler (CDDF), Gilliosa Spurrier-Bernard (MPNE), Emer Cooke (EMA), Nicole Gormley (FDA)
“Session 2: CDDF-AAADV Joint Session – Representativeness in Global Clinical Trials”
Speakers and panelists: Herbert Kim Lyerly (AAADV), Ruth Plummer (CDDF), Marianna Vitaloni, Ph.D. (Digestive Cancer Europe), Lola Fashoyin-Aje, MD, MPH (Independent Consultant), Murielle Mauer (EORTC), Kiran Patel (Johnson and Johnson) and Adrelia Allen (MSD).
We look forward to today’s insightful discussions and open debate with multi-stakeholder audiences and speakers. Stay tuned for more updates!”
More posts featuring Mark Lawler on OncoDaily.